ITGAX and non-small cell lung carcinoma: We also observed a decreased percentage of infiltrating CD11c+HLA-DR+CD14−CD141−CD1c− “DN” cells in tumor compared to distal lung when considering all NSCLC patients investigated (Figures 7D–F).